How Consent Decrees Are Reshaping Antitrust Enforcement in 2026

On May 1, 2026, the Federal Trade Commission entered a consent order requiring 365 Retail Markets to divest Three Square Market, the micromarket kiosk business it would have absorbed through its $848 million acquisition of Cantaloupe. The order, announced with little fanfare outside the trade press, runs fewer than twenty pages. Its central finding is deceptively simple: the combined entity would have controlled more than 70 percent of the market for self-checkout micromarket kiosks installed in workplace breakrooms across the United States. The FTC's complaint, filed concurrently under docket number C-4843, alleged that the transaction would substantially lessen competition in a market most Americans have never heard of. The remedy required was not a fine or a behavioral commitment. It was divestiture, plain and simple.

The case matters far beyond self-checkout kiosks. It illustrates what former enforcement-agency staff describe as a deliberate, methodical shift in how both the FTC and the Department of Justice's Antitrust Division approach consent decrees in the current enforcement cycle. Where prior administrations often accepted conduct remedies, promises not to engage in certain practices, reporting obligations, compliance monitors, the current posture favors structural fixes that alter market configuration itself. In the micromarket kiosk matter, the FTC did not negotiate a behavioral firewall between 365 Retail Markets and Three Square Market. It required a clean sale of the overlapping business. The difference is the difference between a speed limit and a guardrail, and it signals the analytical frame the agencies now bring to every investigation.

That analytical frame received a sharpened articulation in mid-April when the DOJ and FTC jointly intensified their enforcement focus on algorithmic pricing tools. In a widely circulated legal analysis published on April 17, 2026, Snell & Wilmer's antitrust practice group detailed how the agencies have advanced the position that automated pricing systems can constitute a violation of Section 1 of the Sherman Act even absent an explicit agreement among competitors. The theory, which the DOJ briefed in multiple statements of interest filed in private litigation through the first quarter of 2026, holds that when competitors use the same third-party pricing algorithm and that algorithm operates on shared data to set prices in a coordinated fashion, the arrangement may function as a hub-and-spoke conspiracy.

The algorithmic pricing posture is not a new theory, the DOJ first signaled it in a 2024 statement of interest in the Duffy v. Yardi Systems multidistrict litigation concerning rental-property management software, but the 2026 escalation is material. In March, the Antitrust Division filed an amicus brief in a pricing-algorithm case involving revenue management software used by hotel operators, arguing that the use of a common pricing platform that pools competitor-specific occupancy and rate data can satisfy the agreement element of a Sherman Act claim. The Reuters analysis of the enforcement trajectory, published March 20, identified at least four active investigations in which the agencies had issued civil investigative demands targeting the algorithmic pricing practices of firms in residential real estate, hospitality, automotive parts, and grocery retail.

What unifies these efforts is not merely subject matter but remedy design. In each investigation where the staff has recommended a consent decree, the proposed terms include a requirement that the respondent terminate its use of any pricing algorithm that ingests competitor data, not merely modify the algorithm or add compliance overlays. The agencies are writing into consent decrees the proposition that the data input is the violation, not the output.

The agencies are no longer asking whether the algorithm raised prices. They are asking whether the algorithm was fed data it should not have been fed, and they are ordering companies to stop feeding it., Former DOJ trial attorney now in private practice

The consent decree as an instrument has evolved in parallel with the theories it enforces. Where once a decree was understood primarily as a settlement device, a negotiated document that avoided the cost and uncertainty of litigation, the current generation of decrees functions increasingly as a form of quasi-rulemaking. The FTC's micromarket kiosk order, for example, imposes on 365 Retail Markets an obligation to obtain prior Commission approval before acquiring any interest in a competing micromarket business for a period of ten years. That provision, standard in merger consent orders but often limited to five or seven years in prior administrations, is now routinely set at a decade. The extension is not cosmetic. It shifts the default posture from one of monitored compliance to one of presumptive prohibition.

The same dynamic is visible in the consumer protection consent decrees the FTC has pursued in parallel with its competition docket. On April 2, 2026, the FTC and the Maryland Attorney General's office announced a settlement with a Maryland-based auto dealer group accused of deceptive advertising practices, including advertising vehicles that were not actually available for sale and burying mandatory fees in fine print. The consent decree, analyzed in a Nelson Mullins client alert published April 8, required the dealer group to pay restitution and submit to ongoing compliance monitoring. But the structural component was equally significant: the decree mandated that the dealer group provide all-in pricing on every advertised vehicle, a requirement that effectively rewrites the dealership's business model rather than merely penalizing past conduct.

The auto industry enforcement sweep did not stop with one settlement. In late April 2026, the FTC issued warning letters to 97 auto dealer groups nationwide, identifying six categories of illegal conduct: advertising cars already sold, hiding mandatory fees, failing to disclose add-on costs, misrepresenting financing terms, charging consumers for products they did not agree to purchase, and pressuring consumers into unwanted add-ons. The letters, which the FTC made public, served a dual purpose. They put the recipients on notice of specific conduct the agency considers unlawful, and they created a public record that will support enhanced penalties, including civil penalty exposure under Section 5(m)(1)(B) of the FTC Act, in any subsequent enforcement action. A former FTC Bureau of Consumer Protection attorney, now in private practice, described the letter campaign as "a pre-litigation docket builder. Each letter is a marker. The next complaint writes itself."

The DOJ consent decree and the Live Nation precedent

The DOJ's most consequential consent decree of 2026 arrived in the Live Nation-Ticketmaster matter, and it tests every premise of the current enforcement philosophy. In April 2026, a federal jury in the Southern District of New York found that Live Nation and its Ticketmaster subsidiary had maintained an illegal monopoly over large concert venues. The verdict, which followed years of investigation and a multi-state lawsuit joined by more than thirty state attorneys general, represented one of the most significant antitrust trial victories since United States v. Microsoft. Within days, however, the DOJ announced it had reached a settlement with Live Nation that stopped short of the structural separation many observers had expected.

Under the proposed consent decree, Live Nation committed to divest thirteen amphitheaters and to end exclusive ticketing deals at venues the company controls. The settlement also prohibited Live Nation from retaliating against venues that choose alternative ticketing providers, a practice that had been central to the states' case at trial. But the decree did not require Live Nation to divest Ticketmaster itself, the remedy that Senators Amy Klobuchar and Elizabeth Warren had publicly urged. In an April 15 letter to the court, the senators, joined by four colleagues, invoked the Tunney Act to request that the district court scrutinize whether the proposed settlement adequately addressed the jury's findings. "The American people deserve to know whether this settlement reflects the full scope of the jury's verdict or merely the contours of a negotiated compromise," the letter stated, as reported by Variety.

The Tunney Act proceeding in the Live Nation case will be the appellate-level moment to watch. Under the Act, a federal district court must determine that a proposed consent judgment is in the public interest before entering it. The standard of review is deferential, but it is not toothless. Courts have occasionally required modifications to proposed decrees, and the combination of a jury verdict on liability, a high-profile targeted industry, and bipartisan congressional pressure creates a procedural context in which the court may be more willing than usual to probe the adequacy of the remedy. The swing figure on the bench, Judge Analisa Torres of the Southern District of New York, has not yet scheduled the Tunney Act hearing. Her prior rulings in the case, including a November 2025 order denying Live Nation's motion for summary judgment, suggest she will permit a robust evidentiary record.

What the consent decree commits the company to that the marketing language doesn't

The Live Nation decree contains a provision that received little attention in the initial coverage but that outside counsel for several affected competitors have flagged as potentially transformative. Section VIII of the proposed consent judgment requires Live Nation to provide, for a period of seven years, a "data portability interface" that allows venues to export their historical ticket-sales data to any competing ticketing provider in a standardized format. The provision effectively mandates interoperability at the data layer, the same remedy concept that the FTC pursued in its 2024 privacy actions and that European competition authorities have imposed in digital-markets cases. If entered as drafted, it would represent the first time a U.S. antitrust consent decree has imposed a data-portability requirement in a non-technology industry.

The data-portability provision matters because it gets at the structural barrier that makes the ticketing market resistant to competition: the proprietary data moat. Venues that want to switch from Ticketmaster face not only contractual obstacles but the practical impossibility of migrating years of customer data, purchase histories, and seating-preference analytics to a new platform. The consent decree attempts to dismantle that obstacle by making data migration a condition of the decree itself, enforceable through the court's contempt power.

The consent decrees in the micromarket kiosk, auto dealer, algorithmic pricing, and Live Nation matters share a common analytical architecture, and it is this architecture that defines the current enforcement era more than any single case. Each decree begins with a finding that a structural condition produced the harm, a market concentration, an information asymmetry, a data moat. Each decree then imposes a remedy that alters that structural condition rather than merely constraining the conduct that flowed from it. And each decree includes monitoring and reporting provisions that give the agencies ongoing visibility into whether the structural fix held.

The risk in this approach, as several antitrust academics on both political flanks have noted, is that structural remedies are difficult to design correctly and even more difficult to reverse if they produce unintended consequences. A divestiture that places assets in the hands of a buyer who lacks the capacity to compete effectively can entrench the very concentration it was meant to cure. A data-portability mandate that imposes compliance costs beyond what smaller competitors can absorb can inadvertently advantage the incumbent. The agencies are betting that these risks are smaller than the risk of behavioral remedies that companies can game, and they are embedding that bet in every consent decree they file.

The consent decree docket for the remainder of 2026 will provide the test of whether the bet pays off. The FTC's Healthcare Task Force, announced by Chairman Andrew Ferguson in March 2026, has indicated that it expects to bring multiple merger challenges in the hospital and pharmaceutical sectors by the end of the fiscal year. The DOJ's Antitrust Division has civil investigative demands outstanding in at least six algorithmic pricing investigations. Each of those matters will produce either a complaint or a consent decree. How the agencies choose between those two instruments, and what they demand in the decrees they do negotiate, will determine whether the current enforcement posture is remembered as a structural turn in antitrust or as a procedural interlude between administrations. The checkpoints to watch are the Live Nation Tunney Act hearing and the first algorithmic-pricing consent decree to reach a federal judge's signature.